Omega-3 EPA/DHA (AvailOm®)

Omega-3 EPA/DHA (AvailOm®) is a Fatty Acid supplement available in 1 form.

Not all forms of Omega-3 EPA/DHA (AvailOm®) are equal. The form you choose determines how much Omega-3 EPA/DHA (AvailOm®) actually reaches your tissues, and the difference between the best and worst forms can be substantial. AvailOm free fatty acid (FFA) omega-3 provides 3-5x greater bioavailability than standard ethyl ester fish oil because it bypasses the pancreatic lipase requirement for absorption. This is particularly important for individuals with impaired fat digestion, and allows clinically effective omega-3 index elevation at lower doses.

Omega-3 EPA/DHA (AvailOm® High EPA) 2:1 Preferred (T1 Preferred) has a bioavailability rating of high (S1 — best tier). Typical dose range: not yet documented in our database.

AvailOm is a free fatty acid (FFA) form of omega-3 that demonstrates 3-5x greater bioavailability compared to standard ethyl ester fish oil. The FFA form does not require pancreatic lipase for absorption, making it effective even in individuals with impaired fat digestion. Clinical studies confirm rapid elevation of omega-3 index with lower doses compared to traditional fish oil.

Re-esterified triglyceride omega-3 showed 124% relative bioavailability vs natural TG form in human crossover PMID: 20638827

Ethyl ester omega-3 achieved only 73% bioavailability relative to triglyceride form PMID: 21854650

Krill oil phospholipid form shows superior EPA/DHA plasma incorporation at doses under 2000mg PMID: 24124374

Omega-3 EPA/DHA (AvailOm® High EPA) 2:1 is classified as T1 Preferred in the FormulaForge formulary — our top recommendation for Omega-3 EPA/DHA (AvailOm®). It carries a bioavailability rating of high (S1 — best tier), meaning more of the active compound reaches your tissues per dose unit compared to lower-tier forms.

When choosing a Omega-3 EPA/DHA (AvailOm®) supplement, look for the S1 (best absorption) bioavailability tier on the label or formulary listing. T1 Preferred forms have the strongest research-backed evidence for efficient absorption.

Other forms may be appropriate depending on individual goals, cost considerations, and your healthcare provider’s guidance. The best form for you depends on your specific health needs.

For Omega-3 EPA/DHA (AvailOm® High EPA) 2:1, the typical dosing range is not yet documented in our database. Individual dose requirements vary based on health goals, body weight, and existing nutrient intake.

Side Effects: Specific side effect data for these forms is not yet documented in our database. In general, consult your healthcare provider regarding tolerability at higher doses.

These statements are based on structure/function research and have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting or changing a supplement regimen.

The following studies and findings inform our formulary classifications for Omega-3 EPA/DHA (AvailOm®):

Re-esterified triglyceride omega-3 showed 124% relative bioavailability vs natural TG form in human crossover PMID: 20638827

Ethyl ester omega-3 achieved only 73% bioavailability relative to triglyceride form PMID: 21854650

Krill oil phospholipid form shows superior EPA/DHA plasma incorporation at doses under 2000mg PMID: 24124374

Free fatty acid omega-3 form demonstrates highest single-dose bioavailability across all forms PMID: 25884846

Systematic comparison confirming triglyceride superiority over ethyl ester for omega-3 absorption PMID: 33564872

Enteric coating does not significantly improve ethyl ester omega-3 bioavailability vs uncoated TG PMID: 25218856